Majid Sirati-Sabet

8PUBLICATIONS
23CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Cancer geneticsMolecular targetsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jul 28, 2025
Combinatorial Effects of Chrysin with Doxorubicin, 5-Fluorouracil, and Cyclophosphamide on Triple-Negative Breast Cancer Cell Line.

Sedighe Yosefi, Hamid Madanchi, Abbas Pakdel

|Dec 31, 2024
Targeted delivery of chrysin and 5-fluorouracil on MDA-MB-231 cancer cells by a peptide-functionalized L-DOPA-imprinted polymer.

Sedighe Yosefi, Majid Sirati-Sabet, Abbas Pakdel

|Feb 29, 2024
Inhibition of MiR-155 Using Exosomal Delivery of Antagomir Can Up-Regulate PTEN in Triple Negative Breast Cancer.

Javad Razaviyan, Majid Sirati-Sabet, Ali Tafti

|Apr 28, 2023
Comparison of DPPIV Levels in Serum and Tumour of OSCC Patients and Its Correlation with Active Matrix Metalloproteinases 2 and 9.

Abdolkarim Talebi Taheri, Taghi Lashkarbolouki, Abbas Karimi

|Jul 07, 2022
Downregulation of NRARP exerts anti-tumor activities in the breast tumor cells depending on Wnt/β-catenin-mediated signals: The role of miR-130a-3p.

Jafar Poodineh, Majid Sirati-Sabet, Masoumeh Rajabibazl

Pageof 2